$USAC

USA Compression (USAC) Up 6.9% Since Last Earnings Report: Can It Continue?

USA Compression Partners (USAC) reported Q2 2026 earnings of 31 cents per unit, beating estimates and up from last year. Revenue rose 36.8% YoY to $342.1M, driven by contract operations and parts/services. Adjusted EBITDA increased 29.2% to $193.2M. The company reaffirmed its 2026 guidance, expecting adjusted EBITDA between $770M and $800M. Shares have risen 6.9% since the last earnings report, outperforming the S&P 500.

Original reporting
Published Sep 3, 2026, 3:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 4:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$USAC
Neutral
high confidence
Mentioned
$USAC
Relevance
4/10
alphai data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$USACNeutralLow
01

Why it matters

The article is a recap; no new information for traders.

02

Market read

Earnings beat already priced; limited actionable insight.

03

What to watch

Potential future capex needs and debt level of $2.9 bn may constrain upside.

Relevance 4/10Novelty 2/10Timing: post‑earnings month

Background

USA Compression Partners reported Q2 2026 results a month ago, beating estimates and reaffirming guidance.

Company-level read

Ticker impact

$USACNeutralHigh confidence
Context

Q2 2026 earnings beat estimates on revenue and EPS, with guidance reaffirmed, but the report is a month old and the article recaps the numbers.

Expected impact

minimal, likely flat to slight upside as guidance is unchanged

Evidence & confidence

No fresh catalyst; investors have already priced the beat and guidance.

Market effects

Oil & gas services sector shows strong Q2 growth, but no new sector‑wide shift.

U.S. energy services firms may see modest interest.

Limited, as the story is company‑specific and already priced.

Counterpoint

If investors underestimate the durability of the horsepower utilization decline, the stock could face pressure.

Key entities

  • USA Compression Partners

    Largest independent natural gas compression services provider.

Related articles

$USACMed

United States Antimony Corporation Q2 2026 Earnings Call Summary

United States Antimony Corp. reported Q2 2026 revenue down 25% year over year, driven mainly by a 52% fall in realized antimony prices. The company is building $21.6M inventory for its sole-source DLA contract and raised zeolite segment revenue 110%. Full-year 2026 revenue guidance was cut to $60-$75M due to lower pricing; it has $62.2M cash plus a $43.2M Larvotto equity stake.

$USACMed

USA Compression Partners Q2 Earnings Call Highlights

USA Compression Partners (NYSE:USAC) reported Q2 metrics including 4.95 million total fleet horsepower, 92% utilization, and average revenue per revenue-generating horsepower per month of $22.84. Adjusted gross margin was 63.5% and leverage was 3.72x. The firm reaffirmed 2026 outlook for adjusted EBITDA $770m-$800m and distributable cash flow $480m-$510m, plus capex guidance.

$USACMed

USA Compression Partners, LP (USAC): Results of Operations and Financial Condition

USA Compression Partners, LP (USAC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release USA Compression Partners, LP 8115 Preston Road, Suite 700 Dallas, Texas 75225 usacompression.com USA Compression Partners Reports Second-Quarter 2026 Results DALLAS, Texas, August 4, 2026 — USA Compression Partners, LP (NYSE: USAC) (“USA Compression” or

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.

$ORCLMedAI 8/10

Oracle’s AI Earnings Story Is Improving, but the Cash Flow Test Remains

Oracle (ORCL) reported strong Q4 earnings with 21% revenue growth and raised its profit forecast. Morgan Stanley increased its price target to $210, citing improved GPUaaS margins. However, the company faces cash flow pressure due to high capital expenditures for AI infrastructure, with free cash flow at negative $23.7 billion. Hedge funds remain invested, with Fisher Asset Management increasing its stake.

$AVGOMedAI 9/10

Broadcom’s AI Forecast Suggests Hyperscalers Want More Than Just Nvidia GPUs

Broadcom (AVGO) raised its AI chip revenue forecast to $115B for FY2027, up from $100B, and expects $230B in FY2028. This reflects Big Tech's demand for custom chips and networking components, reducing reliance on Nvidia (NVDA). KeyBanc reiterated an Overweight rating and $575 price target for AVGO. AVGO's Q3 revenue rose 86% YoY to $29.6B, but Q4 guidance was slightly below expectations. Hedge funds hold positions in both AVGO and NVDA, with Fisher Asset Management among the top holders.